Together with the previously described genome hypermethylation and potential GNAS mutation‐related upregulation of lipid metabolism (as shown in Figure 1B), this evidence suggests that MGMT silencing being a feature of IPMN‐derived PDAC. This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.